Measles Diagnostic Testing

Clinical Presentation and Diagnostic Approach

The Centers for Disease Control and Prevention recommends serum testing for measles-specific IgM antibody as the most appropriate diagnostic study for a suspected measles case, particularly in an unvaccinated individual 1, 2
A history of measles exposure is a key feature suggesting measles, and symptoms such as fever, cough, watery eyes, and rash starting on the face then spreading, are consistent with measles infection 3, 4
The presence of a faint diffuse macular rash on the lower extremities, in combination with other symptoms, supports the diagnosis of resolving measles infection, which requires laboratory confirmation 1

The American Academy of Pediatrics and the Centers for Disease Control and Prevention recommend serum measles IgM antibody testing as the first-line test for confirming recent measles infection, as it is most sensitive and specific when detected at the time of rash onset 1, 2, 4
IgM antibody testing is most reliable when collected 6-14 days after symptom onset, with a seropositivity rate of 92-100% 1
If the first IgM test is negative but clinical suspicion remains high, a second specimen should be collected at least 72 hours after rash onset 1, 2

The direct-capture IgM EIA method is recommended for its sensitivity and specificity in detecting measles IgM antibodies 1, 2
False-negative results may occur if the specimen is collected too early, within the first 72 hours of rash onset 1, 2
False-positive results can occur with parvovirus infection, other viral infections, or rheumatoid factor positivity 1, 5

Immediate notification of local health departments is essential for suspected measles cases, and laboratory confirmation is crucial for facilitating an appropriate public health response and contact tracing 1, 6
The Centers for Disease Control and Prevention emphasizes the importance of timely reporting and investigation of suspected measles cases, pending laboratory results 1, 6

The Centers for Disease Control and Prevention recommends that measles should be suspected in any patient presenting with fever ≥38.3°C (≥101°F), generalized rash lasting ≥3 days, and at least one of the "three Cs": cough, coryza (runny nose), or conjunctivitis 7
A clinical case requires all three of the following: generalized rash lasting ≥3 days, temperature ≥38.3°C (≥101°F), and at least one of: cough, coryza, or conjunctivitis 7

The Centers for Disease Control and Prevention recommends serum measles-specific IgM antibody testing as the first-line diagnostic test and should be performed on all suspected cases 7
A confirmed case can also be established by significant rise in measles antibody level (four-fold or greater increase between acute and convalescent sera), isolation of measles virus from clinical specimen, or detection of measles virus RNA by reverse transcriptase-PCR 7

Up to 9.3% of healthcare workers born before 1957 may be susceptible to measles despite presumed immunity from natural infection 8
Laboratory confirmation is mandatory for immunocompromised patients, regardless of clinical presentation 9

The Centers for Disease Control and Prevention recommends that suspected and confirmed cases should be reported immediately to local or state health department 7
Do not delay reporting, investigation, or implementation of control measures while awaiting laboratory results 7